Kailesh Gopalbhai, Ph.D. - Publications
Affiliations: | 2004 | Université de Montréal, Montréal, Canada |
Area:
Pharmacology, Molecular Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Voisin L, Julien C, Duhamel S, Gopalbhai K, Claveau I, Saba-El-Leil MK, Rodrigue-Gervais IG, Gaboury L, Lamarre D, Basik M, Meloche S. Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors. Bmc Cancer. 8: 337. PMID 19014680 DOI: 10.1186/1471-2407-8-337 | 0.331 | |||
2003 | Gopalbhai K, Jansen G, Beauregard G, Whiteway M, Dumas F, Wu C, Meloche S. Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1. The Journal of Biological Chemistry. 278: 8118-25. PMID 12506122 DOI: 10.1074/Jbc.M211870200 | 0.604 | |||
2000 | Meloche S, Gopalbhai K, Beatty BG, Scherer SW, Pellerin J. Chromosome mapping of the human genes encoding the MAP kinase kinase MEK1 (MAP2K1) to 15q21 and MEK2 (MAP2K2) to 7q32. Cytogenetics and Cell Genetics. 88: 249-52. PMID 10828601 DOI: 10.1159/000015530 | 0.615 | |||
1998 | Gopalbhai K, Meloche S. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins. Journal of Cellular Physiology. 174: 35-47. PMID 9397154 DOI: 10.1002/(Sici)1097-4652(199801)174:1<35::Aid-Jcp5>3.0.Co;2-H | 0.692 | |||
1996 | Rajotte D, Sadowski HB, Haman A, Gopalbhai K, Meloche S, Liu L, Krystal G, Hoang T. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor. Blood. 88: 2906-16. PMID 8874187 DOI: 10.1182/Blood.V88.8.2906.Bloodjournal8882906 | 0.56 | |||
Show low-probability matches. |